Screener
IBB vs PBE
iShares Biotechnology ETF vs Invesco Biotechnology & Genome ETF
Key differences
- IBB costs 0.14% less per year.
- IBB is significantly larger than PBE — larger funds tend to be more liquid and less likely to close.
Side-by-side comparison
| IBB | PBE | |
|---|---|---|
| Annual cost (TER) | 0.44% | 0.58% |
| Fund size (AUM) | $7.9B | $247M |
| Since | 2001 | 2005 |
| Dividend yield | 0.23% | 1.09% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +39.0% | +34.1% |
| CAGR 3Y | +9.6% | +10.3% |
| CAGR 5Y | +2.7% | +3.3% |
| Sharpe 3Y | 0.38 | 0.41 |
| Volatility 1Y | 19.75% | 18.63% |
| Max drawdown | -39.82% | -37.84% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IBB and PBE
Explore further